These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 28121556)
21. Financing and Distribution of Pharmaceuticals in the United States. Dabora MC; Turaga N; Schulman KA JAMA; 2017 Jul; 318(1):21-22. PubMed ID: 28505252 [No Abstract] [Full Text] [Related]
22. State and federal government mandates are changing the face of pharmacy management. Giaquinta D Manag Care Interface; 2001 May; 14(5):50-2. PubMed ID: 11385948 [No Abstract] [Full Text] [Related]
23. The pharmaceutical industry--prices and progress. Scherer FM N Engl J Med; 2004 Aug; 351(9):927-32. PubMed ID: 15329432 [No Abstract] [Full Text] [Related]
24. The role of bioethics in the international prescription drug market: economics and global justice. Newland SE Penn Bioeth J; 2006; 2(2):8-12. PubMed ID: 17146900 [TBL] [Abstract][Full Text] [Related]
26. Principles of economics crucial to pharmacy students' understanding of the prescription drug market. Rattinger GB; Jain R; Ju J; Mullins CD Am J Pharm Educ; 2008 Jun; 72(3):61. PubMed ID: 18698403 [TBL] [Abstract][Full Text] [Related]
28. Bitter pills. Carpenter D Hosp Health Netw; 2000 Aug; 74(8):48-52. PubMed ID: 10983224 [No Abstract] [Full Text] [Related]
29. User-fee bill passes US Senate, but legislative hurdles remain. Fox JL Nat Biotechnol; 2007 Jun; 25(6):611. PubMed ID: 17557086 [No Abstract] [Full Text] [Related]
30. Patient assistance programs: information is not our enemy. Choudhry NK; Lee JL; Agnew-Blais J; Corcoran C; Shrank WH Health Aff (Millwood); 2009; 28(3):843-4. PubMed ID: 19414896 [No Abstract] [Full Text] [Related]
31. Insurers, PBMs continue to fight for bigger, better drug price discounts. Herman B Mod Healthc; 2015 Aug; 45(31):14. PubMed ID: 26540771 [No Abstract] [Full Text] [Related]
32. The demise of the blockbuster? Cutler DM N Engl J Med; 2007 Mar; 356(13):1292-3. PubMed ID: 17392299 [No Abstract] [Full Text] [Related]
33. Managed care cost containment involving prescription drugs. American Medical Association, Council on Ethical and Judicial Affairs. Food Drug Law J; 1998; 53(1):25-34. PubMed ID: 11795334 [No Abstract] [Full Text] [Related]
35. Voluntary patient assistance programs: additional federal oversight unwarranted. Johnson K Health Aff (Millwood); 2009; 28(3):835-8. PubMed ID: 19414894 [TBL] [Abstract][Full Text] [Related]
36. Affordable prescription drugs for NC consumers: the next challenge. Savage HH N C Med J; 2003; 64(6):298-9. PubMed ID: 14983624 [No Abstract] [Full Text] [Related]
37. The high price of aging. Charatan FB West J Med; 2000 Jun; 172(6):363-4. PubMed ID: 10854373 [No Abstract] [Full Text] [Related]
38. Be creative in consumer cost-sharing for pharmaceutical benefits. Swartz K Inquiry; 1998-1999 Winter; 35(4):365-8. PubMed ID: 10047766 [No Abstract] [Full Text] [Related]
39. Is the market ready for direct pharmaceutical contracting by employers? Giaquinta D Manag Care Interface; 2004 Aug; 17(8):33-4. PubMed ID: 15471109 [No Abstract] [Full Text] [Related]
40. An information infrastructure for the pharmaceutical market. Reinhardt UE Health Aff (Millwood); 2004; 23(1):107-12. PubMed ID: 15002633 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]